Literature DB >> 2704798

Intrahepatic periportal abnormal intensity on MR images: an indication of various hepatobiliary diseases.

O Matsui1, M Kadoya, T Takashima, T Kameyama, J Yoshikawa, S Tamura.   

Abstract

The frequency and degree of intrahepatic periportal abnormal intensity (PAI) on magnetic resonance images in patients with or without various hepatobiliary and pancreatic diseases were analyzed. In 63 patients without hepatobiliary disease, except for a small metastatic liver tumor or cavernous hemangioma, no definite PAI was seen. Definite PAI was seen in all patients with obstructive jaundice, cholangitis, and cholangiocellular carcinoma. It was also clearly seen in all four cases of malignant lymphadenopathy in the hepatoduodenal ligament, in one of two cases of acute hepatitis, and in four of 47 cases of liver cirrhosis. However, in patients with bile duct dilatation or with gallstone or pancreatic disease without obstructive jaundice or cholangitis, no definite PAI was seen. Histologic studies of the liver performed in 23 patients with definite PAI showed edema, ductular proliferation, dilatation of lymph vessels, and inflammatory cell infiltration in portal tracts. It is concluded that definite intrahepatic PAI is a useful sign that indicates the presence of biliary or diffuse hepatic disease.

Entities:  

Mesh:

Year:  1989        PMID: 2704798     DOI: 10.1148/radiology.171.2.2704798

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Comparative performance of non-contrast MRI with HASTE vs. contrast-enhanced MRI/3D-MRCP for possible choledocholithiasis in hospitalized patients.

Authors:  Stella K Kang; Laura Heacock; Ankur M Doshi; Justin R Ream; Jeffrey Sun; James S Babb
Journal:  Abdom Radiol (NY)       Date:  2017-06

2.  Integrative role of MRI in the evaluation of primary biliary cirrhosis.

Authors:  Jelena Djokić Kovač; Rada Ješić; Dejana Stanisavljević; Bojan Kovač; Bojan Banko; Petar Seferović; Ružica Maksimović
Journal:  Eur Radiol       Date:  2011-10-12       Impact factor: 5.315

Review 3.  MRI of diffuse liver disease: characteristics of acute and chronic diseases.

Authors:  Surya Chundru; Bobby Kalb; Hina Arif-Tiwari; Puneet Sharma; James Costello; Diego R Martin
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

4.  Hepatic and splenic sarcoidosis: ultrasound and MR imaging.

Authors:  A Kessler; D G Mitchell; H L Israel; B B Goldberg
Journal:  Abdom Imaging       Date:  1993

5.  Periportal halo: a CT sign of liver disease.

Authors:  T L Lawson; M K Thorsen; S J Erickson; R S Perret; F A Quiroz; W D Foley
Journal:  Abdom Imaging       Date:  1993

6.  Bile duct disease: prospective comparison of ERCP, CT, and fat suppression MRI.

Authors:  R C Semelka; J P Shoenut; M A Kroeker; H Hricak; G Y Minuk; C S Yaffe; A B Micflikier
Journal:  Gastrointest Radiol       Date:  1992

7.  Computed tomography findings in acute decompensated heart failure: periportal collar sign and lymphedema in the hepatoduodenal ligament and retroperitoneal space.

Authors:  Hiroyuki Takeda; Kenichi Kamachi; Toshiya Yoshida; Hirotaka Miyazono; Tadao Kuruma; Shigeru Fujii
Journal:  Springerplus       Date:  2015-06-21

8.  The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis.

Authors:  Ying Meng; Yuting Liang; Mingming Liu
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

9.  Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images?

Authors:  Hiromitsu Onishi; Daniel Theisen; Reinhart Zachoval; Maximilian F Reiser; Christoph J Zech
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

10.  Excretion of Necrotic Hepatocellular Carcinoma Tissues into Hepatic Lymphatic Vessels after Conventional Transarterial Chemoembolization.

Authors:  Shiro Miyayama; Masashi Yamashiro; Rie Ikeda; Junichi Matsumoto; Nobuhiko Ogawa; Naoko Sakuragawa; Teruyuki Ueda
Journal:  Interv Radiol (Higashimatsuyama)       Date:  2021-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.